- Home
- IKT vs SUNS Comparison
IKT vs SUNS Comparison
Compare IKT & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SUNS
- Stock Information
- Founded
- IKT 2008
- SUNS 2023
- Country
- IKT United States
- SUNS United States
- Employees
- IKT N/A
- SUNS N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SUNS Real Estate Investment Trusts
- Sector
- IKT Health Care
- SUNS Real Estate
- Exchange
- IKT Nasdaq
- SUNS Nasdaq
- Market Cap
- IKT 131.6M
- SUNS 148.2M
- IPO Year
- IKT 2020
- SUNS N/A
- Fundamental
- Price
- IKT $1.66
- SUNS $10.84
- Analyst Decision
- IKT Buy
- SUNS Strong Buy
- Analyst Count
- IKT 2
- SUNS 3
- Target Price
- IKT $8.00
- SUNS $13.42
- AVG Volume (30 Days)
- IKT 126.7K
- SUNS 61.1K
- Earning Date
- IKT 08-13-2025
- SUNS 08-13-2025
- Dividend Yield
- IKT N/A
- SUNS 11.27%
- EPS Growth
- IKT N/A
- SUNS N/A
- EPS
- IKT N/A
- SUNS 1.02
- Revenue
- IKT N/A
- SUNS $13,066,680.00
- Revenue This Year
- IKT N/A
- SUNS $148.89
- Revenue Next Year
- IKT N/A
- SUNS $43.47
- P/E Ratio
- IKT N/A
- SUNS $10.70
- Revenue Growth
- IKT N/A
- SUNS 1342.10
- 52 Week Low
- IKT $1.12
- SUNS $7.80
- 52 Week High
- IKT $4.20
- SUNS $15.74
- Technical
- Relative Strength Index (RSI)
- IKT 35.43
- SUNS N/A
- Support Level
- IKT $1.91
- SUNS N/A
- Resistance Level
- IKT $2.07
- SUNS N/A
- Average True Range (ATR)
- IKT 0.11
- SUNS 0.00
- MACD
- IKT -0.03
- SUNS 0.00
- Stochastic Oscillator
- IKT 0.00
- SUNS 0.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.